This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Contrast Injection Lines Market

Market Insights on Contrast Injection Lines covering sales outlook, demand forecast & up-to-date key trends

Contrast Injection Lines Market by Product Type, Material Type, Application, End User & Region - Forecast 2022 - 2032

Contrast Injection Lines Market Snapshot

The global contrast injection lines market size is likely to be valued at US$ 5.1 Billion in 2022 and exhibit growth at a CAGR of 4.7% in the forecast period from 2022 to 2032. Increasing need to perform MRI, X-Ray, and CT scans is likely to push the demand for contrast injection lines in the upcoming years. According to FMI, the global contrast injection lines market is set to reach US$ 11.2 Billion in 2032.

Report Attribute

Details

Contrast Injection Lines Market Estimated Base Year Value (2021)

US$ 4.3 Billion

Contrast Injection Lines Market Expected Market Value (2022)

US$ 5.1 Billion

Contrast Injection Lines Market Anticipated Forecast Value (2032)

US$ 11.2 Billion

Contrast Injection Lines Market Projected Growth Rate (2022-2032)

4.7% CAGR

Contrast injection lines are extensively used to improve images and scans. The contrast dye is inserted through injections in a patient during various diagnostic imaging procedures.

Contrast dye is usually injected through the cannula placed either in the vein or the artery. It is a colorless fluid that is used to propel the contrast of fluids or structures within the body during medical imaging procedures.

The demand for contrast injection lines is projected to surge at a fast pace in the assessment period stoked by their increasing usage during angiographic intervention. The rising number of numerous radiological examination procedures because of the increasing patient pool in various parts of the globe is also set to augment the market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How are Cost-effective Healthcare Devices Augmenting the Contrast Injection Lines Market Growth?

Rising prevalence of various chronic disorders is likely to spur the sales of contrast injection lines in the forthcoming years. This is attributable to the urgent need for numerous radiological interventional procedures across the globe. Increasing healthcare expenditure, especially in developed countries is another vital factor that is likely to drive the global market.

Moreover, the availability of cost-effective medical care services and devices with the ongoing development of new products is likely to boost the market. High disposable income of people and surging cases of vascular disorders are also anticipated to foster the need for diagnostic imaging procedures, thereby propelling the market.

Which Factors May Obstruct the Contrast Injection Lines Market Growth?

Various risks, such as nephrogenic systemic fibrosis and contrast induced nephropathy related to the insertion of contrast injection may hamper the market growth. In addition to that, the high cost of contrast media injection depending on the type of injectors can obstruct the demand. In emerging economies, the lack of knowledge about these injections owing to safety and hygiene issues is also projected to hinder the contrast injection lines market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Is Cardiovascular Disease Propelling the North America Contrast Injection Lines Market?

Based on region, North America is projected to lead by procuring the largest contrast injection lines market share in the near future. The rising prevalence of cardiovascular diseases across the U.S. and Canada is anticipated to bolster the regional market. Also, the increasing number of radiological examination and interventional procedures is set to drive the market.

As per the Centers for Disease Control and Prevention (CDC), in the U.S., about 659,000 people die due to heart attack every year, whereas one person dies every 36 seconds in this country from cardiovascular diseases. This trend is likely to continue throughout the forthcoming years, thereby propelling the North America market.

How is the Geriatric Population Accelerating the Asia Pacific Contrast Injection Lines Market?

Asia Pacific is likely to remain in the second position in the evaluation period owing to ongoing investments by government bodies to develop the healthcare infrastructure in India and China. The high demand for diagnostic imaging procedures backed by the ever-increasing geriatric population is another crucial factor that is estimated to propel the contrast injection lines market size in future.

Rapid advancement in the field of radiological interventional procedures, such as angiography, computed tomography, and fluoroscopy is also set to propel the regional market. In addition to that, the surging demand for contrast agents in this region to evaluate the accurate body site scans is expected to bode well for the Asia Pacific market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the renowned companies present in the global contrast injection lines market include Argon Medical Devices Inc., Shenzhen Axwei Medical Technology Co., Ltd., AngioDynamics (Navilyst Medical, Inc.), George Philips Medical Engineering Pvt. Ltd., B. Braun Melsungen AG, Merit Medical Systems, Inc., Dickinson and Company, and Becton among others.

Key players in the market are investing huge sums in research and development activities to come up with novel products and expand their existing portfolios. A few other companies are engaging in joint ventures and acquisitions with healthcare organizations to deliver their in-house products. Meanwhile, a handful of companies are striving to broaden their geographic presence by opening new manufacturing facilities.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.7% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Material Type
  • Application
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Argon Medical Devices Inc.
  • Shenzhen Axwei Medical Technology Co., Ltd.
  • AngioDynamics (Navilyst Medical, Inc.)
  • George Philips Medical Engineering Pvt. Ltd.
  • B. Braun Melsungen AG
  • Merit Medical Systems, Inc.
  • Dickinson and Company
  • Becton

Customization

Available Upon Request

Key Segments Profiled in the Contrast Injection Lines Industry Survey

By Product Type:

  • High-Pressure Contrast Injection Line
  • Low-Pressure Contrast Injection Line

By Material Type:

  • Polyurethane
  • PVC
  • Coextruded nylon/urethane
  • Others

By Application:

  • CT Examination
  • MRI Examination
  • Angiography
  • X-Ray Examination
  • Others

By End User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global contrast injection lines market is set to exceed US$ 11.2 Billion in 2032.

North America is set to lead the contrast injection lines market in the forecast period.

Argon Medical Devices Inc., Shenzhen Axwei Medical Technology Co., Ltd., AngioDynamics (Navilyst Medical, Inc.), and George Philips Medical Engineering Pvt. Ltd. are some of the renowned companies in the contrast injection lines market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Nasal Sampling Lines Market

Published : October 2020

Healthcare

Insect cell lines Market

Published : April 2020

Healthcare

Cryopreservation Cell Lines Market

Published : December 2019

Healthcare

Contrast Injection Lines Market

Published : April 2019

Google translate

Contrast Injection Lines Market